Cover Image
市場調查報告書

自體免疫疾病診斷設備:醫療設備的開發平台評估

Auto-Immune Diseases Diagnostic Tests - Medical Devices Pipeline Assessment, 2017

出版商 GlobalData 商品編碼 351353
出版日期 內容資訊 英文 382 Pages
訂單完成後即時交付
價格
Back to Top
自體免疫疾病診斷設備:醫療設備的開發平台評估 Auto-Immune Diseases Diagnostic Tests - Medical Devices Pipeline Assessment, 2017
出版日期: 2017年10月01日 內容資訊: 英文 382 Pages
簡介

本報告提供自體免疫疾病診斷設備的開發中產品相關調查,提供您各開發階段趨勢和產品的主要開發企業,現在進行中的臨床實驗,產業的最近事件等資訊。

第1章 目錄

第2章 簡介

  • 自體免疫疾病 概要

第3章 開發中的產品

  • 開發中產品:各開發階段
  • 開發中產品:地區 (國家) 別
  • 開發中產品:法規途徑別
  • 開發中產品:核准時期別 (估計)

第4章 自體免疫疾病診斷設備 - 正在開發的開發中產品:各企業

  • 開發企業 - 開發中產品:各開發階段
  • 開發中產品:各開發階段

第5章 自體免疫疾病診斷設備的開發企業與產品概要

  • Adaptive Biotechnologies Corporation
  • Agena Bioscience, Inc
  • Albert-Ludwigs-Universitat Freiburg
  • Alere Inc.
  • Amarantus Bioscience Holdings, Inc.
  • Amdix B.V.
  • Analyticon Biotechnologies AG
  • apDia n.v.
  • Autoimmune Technologies, LLC
  • Beckman Coulter, Inc.
  • BG Medicine, Inc.
  • Biocortech
  • Biogen, Inc.
  • Biomedal S.L.
  • Biomerica, Inc.
  • Bionure Farma, S.L.
  • Bio-Rad Laboratories, Inc.
  • BioRap Technologies Ltd.
  • Boston University
  • CareDx, Inc.
  • CD Diagnostics, Inc.
  • Chronix Biomedical, Inc.
  • Co-Diagnostics HBDC, Inc.
  • Crescendo Bioscience, Inc.
  • Digna Biotech, S.L.
  • Durin Technologies, Inc.
  • Enterome Bioscience SA
  • Ezose Sciences Inc.
  • Flamentera AG
  • Genalyte, Inc.
  • Genentech, Inc.
  • GeNeuro SA
  • Glycominds Ltd.
  • Grifols, S.A.
  • Hannover Medical School
  • Helmholtz Centre for Infection Research
  • HOB Biotech Group Co., Ltd.
  • Hospital for Special Surgery
  • Hycor Biomedical Inc.
  • Ignyta, Inc.
  • ImmusanT, Inc.
  • Innobiochips
  • INOVA Diagnostics, Inc.
  • Institut National de la Sante et de la Recherche Medicale
  • Is Diagnostics
  • LineaGen, Inc.
  • Lophius Biosciences GmbH
  • Louisville Bioscience, Inc.
  • Max-Delbruck-Centrum fur Molekulare Medizin (MDC)
  • Medica Corporation
  • Metabolomic Technologies Inc.
  • Metanomics Health GmbH
  • MSDx, Inc.
  • Myriad Genetics, Inc.
  • Nanosphere, Inc.
  • Neuro Vigor, LLC
  • Northwestern University
  • NoToPharm s.r.l.
  • NOWDiagnostics
  • OmniBiome Therapeutics Inc.
  • One Way Liver Genomics, S.L.
  • OPKO Health, Inc.
  • Oxford Gene Technology Limited
  • Oxford Immunotec Limited
  • Pediatric Bioscience, LLC
  • Progentec Diagnostics, Inc.
  • Protagen AG
  • ProteinLogic Ltd
  • Quanterix Corporation
  • Regulus Therapeutics Inc.
  • Rice University
  • Roche Diagnostics International Ltd.
  • Shuwen Biotech Co. Ltd.
  • Singulex, Inc.
  • SomaLogic, Inc.
  • Southern Illinois University Carbondale
  • SQI Diagnostics Inc.
  • The Johns Hopkins University
  • The Walter and Eliza Hall Institute of Medical Research
  • TheraDiag SA
  • Thermo Fisher Scientific Inc.
  • Toscana Biomarkers Srl
  • Univalue Valorizacion, S.L.
  • University of California, San Francisco
  • University of Chicago
  • University of Colorado
  • University of Florida
  • University of Manchester
  • University of Oxford
  • University of Pecs
  • University Rovira i Virgili
  • US Biomarkers, Inc.
  • Washington University in St. Louis
  • XAir Diagnostics B.V.
  • XEPTAGEN SpA
  • Yale University

第6章 自體免疫疾病診斷設備 - 最近的事件

第7章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0459EPD

GlobalData's Medical Devices sector report, "Auto-Immune Diseases Diagnostic Tests - Medical Devices Pipeline Assessment, 2017" provides an overview of Auto-Immune Diseases Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Auto-Immune Diseases Diagnostic Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Auto-Immune Diseases Diagnostic Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Auto-Immune Diseases Diagnostic Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Auto-Immune Diseases Diagnostic Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 8
  • 1.2 List of Figures 17

2 Introduction 18

  • 2.1 Auto-Immune Diseases Diagnostic Tests Overview 18

3 Products under Development 19

  • 3.1 Auto-Immune Diseases Diagnostic Tests - Pipeline Products by Stage of Development 19
  • 3.2 Auto-Immune Diseases Diagnostic Tests - Pipeline Products by Territory 20
  • 3.3 Auto-Immune Diseases Diagnostic Tests - Pipeline Products by Regulatory Path 21
  • 3.4 Auto-Immune Diseases Diagnostic Tests - Pipeline Products by Estimated Approval Date 22
  • 3.5 Auto-Immune Diseases Diagnostic Tests - Ongoing Clinical Trials 23

4 Auto-Immune Diseases Diagnostic Tests - Pipeline Products under Development by Companies 24

  • 4.1 Auto-Immune Diseases Diagnostic Tests Companies - Pipeline Products by Stage of Development 24
  • 4.2 Auto-Immune Diseases Diagnostic Tests - Pipeline Products by Stage of Development 28

5 Auto-Immune Diseases Diagnostic Tests Companies and Product Overview 34

  • 5.1 Adaptive Biotechnologies Corp Company Overview 34
  • 5.2 Agena Bioscience, Inc Company Overview 37
  • 5.3 Albert Ludwigs University of Freiburg Company Overview 38
  • 5.4 Alere Inc Company Overview 41
  • 5.5 Amarantus Bioscience Holdings Inc Company Overview 43
  • 5.6 Analyticon Biotechnologies AG Company Overview 45
  • 5.7 apDia nv Company Overview 46
  • 5.8 Autoimmune Technologies LLC Company Overview 47
  • 5.9 Banyan Biomarkers Inc Company Overview 51
  • 5.10 Beckman Coulter Inc Company Overview 52
  • 5.11 BG Medicine Inc Company Overview 53
  • 5.12 Biocortech SAS Company Overview 54
  • 5.13 Biogen Inc Company Overview 55
  • 5.14 Biomedal SL Company Overview 56
  • 5.15 Biomerica, Inc. Company Overview 58
  • 5.16 Bionure Farma SL Company Overview 59
  • 5.17 CD Diagnostics, Inc. Company Overview 60
  • 5.18 CDI Laboratories Inc Company Overview 61
  • 5.19 Chronix Biomedical Inc Company Overview 62
  • 5.20 Cincinnati Children's Hospital Medical Center Company Overview 64
  • 5.21 Co-Diagnostics HBDC, Inc. Company Overview 65
  • 5.22 Cofactor Genomics Inc Company Overview 66
  • 5.23 Crescendo Bioscience Inc Company Overview 68
  • 5.24 Digna Biotech SL Company Overview 72
  • 5.25 Durin Technologies, Inc. Company Overview 74
  • 5.26 EMD Millipore Corp Company Overview 75
  • 5.27 Enterome Bioscience SA Company Overview 76
  • 5.28 Ezose Sciences Inc. Company Overview 78
  • 5.29 Flamentera AG Company Overview 79
  • 5.30 French National Institute of Health and Medical Research Company Overview 80
  • 5.31 Genalyte, Inc. Company Overview 81
  • 5.32 GeNeuro SA Company Overview 82
  • 5.33 Glycominds Ltd. Company Overview 83
  • 5.34 Grifols SA Company Overview 84
  • 5.35 Hannover Medical School Company Overview 85
  • 5.36 Helmholtz Centre for Infection Research Company Overview 86
  • 5.37 HOB Biotech Group Suzhou Co Ltd Company Overview 87
  • 5.38 Hospital for Special Surgery Company Overview 88
  • 5.39 Hummingbird Diagnostics GmbH Company Overview 89
  • 5.40 Hycor Biomedical Inc Company Overview 91
  • 5.41 Ignyta Inc Company Overview 93
  • 5.42 IMMUNARRAY LTD. Company Overview 96
  • 5.43 Immunovia AB Company Overview 99
  • 5.44 ImmusanT Inc Company Overview 100
  • 5.45 Inflammatix Inc Company Overview 102
  • 5.46 Innobiochips Company Overview 103
  • 5.47 Inova Diagnostics Inc Company Overview 104
  • 5.48 Iquity Labs Inc Company Overview 110
  • 5.49 Iron Horse Diagnostics, Inc. Company Overview 112
  • 5.50 Is Diagnostics Company Overview 114
  • 5.51 John Hopkins University Company Overview 115
  • 5.52 LineaGen Inc Company Overview 117
  • 5.53 Lophius Biosciences GmbH Company Overview 118
  • 5.54 Louisville Bioscience, Inc. Company Overview 119
  • 5.55 Max-Delbruck-Centrum fur Molekulare Medizin (MDC) Company Overview 123
  • 5.56 Medica Corp Company Overview 124
  • 5.57 Metabiomics Corporation Company Overview 127
  • 5.58 Metabolomic Technologies Inc Company Overview 129
  • 5.59 Metanomics Health GmbH Company Overview 132
  • 5.60 MSDx Inc Company Overview 133
  • 5.61 Myriad Genetics Inc Company Overview 137
  • 5.62 Nanosphere Inc Company Overview 138
  • 5.63 Neuro Vigor LLC Company Overview 139
  • 5.64 Northwestern University Company Overview 140
  • 5.65 NoToPharm srl Company Overview 141
  • 5.66 Numares AG Company Overview 146
  • 5.67 OmniBiome Therapeutics Inc (Inactive) Company Overview 147
  • 5.68 One Way Liver SL Company Overview 148
  • 5.69 OPKO Health Inc Company Overview 149
  • 5.70 Oxford Gene Technology Ltd Company Overview 150
  • 5.71 Oxford Immunotec Ltd Company Overview 151
  • 5.72 Pediatric Bioscience, LLC Company Overview 152
  • 5.73 Progentec Diagnostics, Inc. Company Overview 153
  • 5.74 Protagen AG Company Overview 154
  • 5.75 ProteinLogic Ltd Company Overview 159
  • 5.76 Quanterix Corp Company Overview 160
  • 5.77 Rambam Health Care Campus Company Overview 161
  • 5.78 Ramon y Cajal Institute of Health Research Company Overview 162
  • 5.79 Rappaport Family Institute for Research in the Medical Science Company Overview 163
  • 5.80 Regulus Therapeutics Inc Company Overview 164
  • 5.81 Roche Diagnostics International Ltd Company Overview 165
  • 5.82 Shuwen Biotech Co Ltd Company Overview 169
  • 5.83 Siemens Healthcare GmbH Company Overview 170
  • 5.84 SomaLogic Inc Company Overview 171
  • 5.85 Southern Illinois University Carbondale Company Overview 172
  • 5.86 SQI Diagnostics Inc Company Overview 174
  • 5.87 Statens Serum Institut Company Overview 179
  • 5.88 TBG Diagnostics Ltd Company Overview 180
  • 5.89 The Walter and Eliza Hall Institute of Medical Research Company Overview 181
  • 5.90 TheraDiag SA Company Overview 182
  • 5.91 Thermo Fisher Scientific Inc Company Overview 184
  • 5.92 Toscana Biomarkers Srl Company Overview 198
  • 5.93 University Health Network Company Overview 202
  • 5.94 University of California San Francisco Company Overview 203
  • 5.95 University of Chicago Company Overview 204
  • 5.96 University of Colorado Company Overview 205
  • 5.97 University of Gottingen Company Overview 206
  • 5.98 University of Illinois at Chicago Company Overview 208
  • 5.99 University of Manchester Company Overview 209
  • 5.100 University of Maryland Baltimore Company Overview 211
  • 5.101 University of Missouri Company Overview 212
  • 5.102 University of Oxford Company Overview 213
  • 5.103 University of Pecs Company Overview 216
  • 5.104 University of Southern California Company Overview 217
  • 5.105 University Rovira i Virgili Company Overview 218
  • 5.106 US Biomarkers Inc Company Overview 219
  • 5.107 Washington University in St Louis Company Overview 220
  • 5.108 XEPTAGEN SpA Company Overview 221
  • 5.109 Yale University Company Overview 222

6 Auto-Immune Diseases Diagnostic Tests - Recent Developments 223

  • 6.1 Sep 06, 2017: Sandra Cole Appointed Vice President and Chief Compliance Officer for OPKO's BioReference Laboratories 223
  • 6.2 Aug 24, 2017: SQI Diagnostics Reports Third Quarter 2017 Results 223
  • 6.3 Aug 17, 2017: Victoria Laughman Named Executive Vice President of Sales for OPKO's BioReference Laboratories 225
  • 6.4 Aug 15, 2017: Ms. Teresa Regan Joins Neon Therapeutics as VP of Human Resources 226
  • 6.5 Aug 10, 2017: CareDx Reports Second Quarter 2017 Financial Results 226
  • 6.6 Aug 07, 2017: Luminex Reports Second Quarter 2017 Financial Results 227
  • 6.7 Aug 03, 2017: Alere Reports Second Quarter 2017 Financial Results 228
  • 6.8 Aug 03, 2017: Bio-Rad Reports Second-Quarter 2017 Financial Results 228
  • 6.9 Aug 03, 2017: Diasorin Group Reports Strong Growth in Revenues and Profitability in Q2 2017 229
  • 6.10 Aug 01, 2017: Regulus Reports Second Quarter 2017 Financial Results and Recent Events 233
  • 6.11 Jul 31, 2017: GeNeuro Updates on Cash, Revenue and Activities at Q2 2017 233
  • 6.12 Jul 28, 2017: Grifols increases its revenues by 12.3% to EUR 2,192 million driven by growth of its main divisions 234
  • 6.13 Jul 27, 2017: Adaptive Biotechnologies Expands Leadership to Bolster Integration of Immune Profiling into Clinical Care Setting 241
  • 6.14 Jul 27, 2017: QIAGEN Reports Results for Second Quarter and First Half of 2017 241
  • 6.15 Jul 26, 2017: Thermo Fisher Scientific Reports Second Quarter 2017 Results 245
  • 6.16 Jul 25, 2017: Theradiag: Further Strong Sales Growth in the First Half of 2017: +9% 247
  • 6.17 Jul 20, 2017: Trinity Biotech Announces Results for Q2, 2017 247
  • 6.18 Jul 18, 2017: Quanterix Boosts Investments in its Accelerator Lab to Support Rapid Growth of Simoa Technology 249
  • 6.19 Jul 17, 2017: Leading pancreatic cancer expert on early symptoms Professor Stephen Pereira at University College London joins Immunovia's Scientific Advisory Board 250
  • 6.20 Jul 13, 2017: Dr. Jaymie Sawyer, Vice President of R&D, Transitions to Lead Scientific Advisory Committee 250
  • 6.21 Jul 12, 2017: Enterome Appoints Mary Thistle to its Board of Directors 250

7 Appendix 377

  • 7.1 Methodology 377
  • 7.2 About GlobalData 380
  • 7.3 Contact Us 380
  • 7.4 Disclaimer 380

List of Tables

1.1 List of Tables

  • Table 1: Auto-Immune Diseases Diagnostic Tests - Pipeline Products by Stage of Development 21
  • Table 2: Auto-Immune Diseases Diagnostic Tests - Pipeline Products by Territory 22
  • Table 3: Auto-Immune Diseases Diagnostic Tests - Pipeline Products by Regulatory Path 23
  • Table 4: Auto-Immune Diseases Diagnostic Tests - Pipeline Products by Estimated Approval Date 24
  • Table 5: Auto-Immune Diseases Diagnostic Tests - Ongoing Clinical Trials 25
  • Table 6: Auto-Immune Diseases Companies - Pipeline Products by Stage of Development 26
  • Table 7: Auto-Immune Diseases Diagnostic Tests - Pipeline Products by Stage of Development 30
  • Table 8: Adaptive Biotechnologies Corp Pipeline Products & Ongoing Clinical Trials Overview 36
  • Table 9: Diagnostic Test - Auto-Immune Disease - Product Status 36
  • Table 10: Diagnostic Test - Auto-Immune Disease - Product Description 36
  • Table 11: Non-Invasive Diagnostic Test - Celiac Disease - Product Status 37
  • Table 12: Non-Invasive Diagnostic Test - Celiac Disease - Product Description 37
  • Table 13: Pre - Symptomatic Biomarker - Type 1 Diabetes - Product Status 37
  • Table 14: Pre - Symptomatic Biomarker - Type 1 Diabetes - Product Description 38
  • Table 15: Agena Bioscience, Inc Pipeline Products & Ongoing Clinical Trials Overview 39
  • Table 16: AttoSense Lupus Panel - Product Status 39
  • Table 17: AttoSense Lupus Panel - Product Description 39
  • Table 18: Albert Ludwigs University of Freiburg Pipeline Products & Ongoing Clinical Trials Overview 40
  • Table 19: Biomarker Based Assay - Systemic Sclerosis - Product Status 40
  • Table 20: Biomarker Based Assay - Systemic Sclerosis - Product Description 40
  • Table 21: Circulating mtDNA Based Assay - Autoimmune and Autoinflammatory Diseases - Product Status 41
  • Table 22: Circulating mtDNA Based Assay - Autoimmune and Autoinflammatory Diseases - Product Description 41
  • Table 23: Mitochondrial DNA Based Assay - Autoimmune and Autoinflammatory Diseases - Product Status 41
  • Table 24: Mitochondrial DNA Based Assay - Autoimmune and Autoinflammatory Diseases - Product Description 42
  • Table 25: Alere Inc Pipeline Products & Ongoing Clinical Trials Overview 43
  • Table 26: AIMS System - Cardiolipin IgG Test - Product Status 43
  • Table 27: AIMS System - Cardiolipin IgG Test - Product Description 43
  • Table 28: AtheNA Multi-Lyte System - Cardiolipin IgG Test - Product Status 44
  • Table 29: AtheNA Multi-Lyte System - Cardiolipin IgG Test - Product Description 44
  • Table 30: Amarantus Bioscience Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 45
  • Table 31: Diagnostic Assay - Neuromyelitis Optica - Product Status 45
  • Table 32: Diagnostic Assay - Neuromyelitis Optica - Product Description 45
  • Table 33: Diagnostic Assay - Paraneoplastic Disease - Product Status 46
  • Table 34: Diagnostic Assay - Paraneoplastic Disease - Product Description 46
  • Table 35: Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview 47
  • Table 36: Turbitex IgA - Product Status 47
  • Table 37: Turbitex IgA - Product Description 47
  • Table 38: apDia nv Pipeline Products & Ongoing Clinical Trials Overview 48
  • Table 39: Diagnostic Test - MS (Multiple Sclerosis) - Product Status 48
  • Table 40: Diagnostic Test - MS (Multiple Sclerosis) - Product Description 48
  • Table 41: Autoimmune Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 49
  • Table 42: Anti-Squalene Antibody Assay - Product Status 49
  • Table 43: Anti-Squalene Antibody Assay - Product Description 49
  • Table 44: Autoimmune Disease Virus Assay - Graves' Disease - Product Status 50
  • Table 45: Autoimmune Disease Virus Assay - Graves' Disease - Product Description 50
  • Table 46: Autoimmune Disease Virus Assay - Juvenile Rheumatoid Arthritis - Product Status 50
  • Table 47: Autoimmune Disease Virus Assay - Juvenile Rheumatoid Arthritis - Product Description 51
  • Table 48: Autoimmune Disease Virus Assay - Sjogren Syndrome - Product Status 51
  • Table 49: Autoimmune Disease Virus Assay - Sjogren Syndrome - Product Description 51
  • Table 50: Autoimmune Disease Virus Assay - Systemic Lupus Erythematosus - Product Status 52
  • Table 51: Autoimmune Disease Virus Assay - Systemic Lupus Erythematosus - Product Description 52
  • Table 52: Banyan Biomarkers Inc Pipeline Products & Ongoing Clinical Trials Overview 53
  • Table 53: Diagnostic Assay - Parkinson's Disease - Product Status 53
  • Table 54: Diagnostic Assay - Parkinson's Disease - Product Description 53
  • Table 55: Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview 54
  • Table 56: SYNCHRON LXi 725 Anti-dsDNA Assay - Product Status 54
  • Table 57: SYNCHRON LXi 725 Anti-dsDNA Assay - Product Description 54
  • Table 58: BG Medicine Inc Pipeline Products & Ongoing Clinical Trials Overview 55
  • Table 59: Diagnostic Assay - Multiple Sclerosis - Product Status 55
  • Table 60: Diagnostic Assay - Multiple Sclerosis - Product Description 55
  • Table 61: Biocortech SAS Pipeline Products & Ongoing Clinical Trials Overview 56
  • Table 62: Blood Test - Cognitive Deficits - Product Status 56
  • Table 63: Blood Test - Cognitive Deficits - Product Description 56
  • Table 64: Biogen Inc Pipeline Products & Ongoing Clinical Trials Overview 57
  • Table 65: Companion Diagnostic Test - Sjogren's Syndrome - Product Status 57
  • Table 66: Companion Diagnostic Test - Sjogren's Syndrome - Product Description 57
  • Table 67: Biomedal SL Pipeline Products & Ongoing Clinical Trials Overview 58
  • Table 68: ELISA DELIAC GFD - Product Status 58
  • Table 69: ELISA DELIAC GFD - Product Description 58
  • Table 70: IVYLISA DGP8 - Product Status 59
  • Table 71: IVYLISA DGP8 - Product Description 59
  • Table 72: Stick DELIAC GFD - Product Status 59
  • Table 73: Stick DELIAC GFD - Product Description 59
  • Table 74: Biomerica, Inc. Pipeline Products & Ongoing Clinical Trials Overview 60
  • Table 75: Transglutaminase Elisa Kit - Product Status 60
  • Table 76: Transglutaminase Elisa Kit - Product Description 60
  • Table 77: Bionure Farma SL Pipeline Products & Ongoing Clinical Trials Overview 61
  • Table 78: BN - 301 Diagnostic/Prognostic Test - Product Status 61
  • Table 79: BN - 301 Diagnostic/Prognostic Test - Product Description 61
  • Table 80: CD Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 62
  • Table 81: Cygnasure Diagnostic Immunoassay - Lupus - Product Status 62
  • Table 82: Cygnasure Diagnostic Immunoassay - Lupus - Product Description 62
  • Table 83: CDI Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 63
  • Table 84: Diagnostic Test - Systemic Lupus Erythematosus - Product Status 63
  • Table 85: Diagnostic Test - Systemic Lupus Erythematosus - Product Description 63
  • Table 86: Chronix Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 64
  • Table 87: Companion Diagnostic Test - Multiple Sclerosis - Product Status 64
  • Table 88: Companion Diagnostic Test - Multiple Sclerosis - Product Description 64
  • Table 89: Companion Diagnostic Test - Systemic Lupus Erythematous - Product Status 65
  • Table 90: Companion Diagnostic Test - Systemic Lupus Erythematous - Product Description 65
  • Table 91: Cincinnati Children's Hospital Medical Center Pipeline Products & Ongoing Clinical Trials Overview 66
  • Table 92: Biomarker Panel - Lupus Nephritis - Product Status 66
  • Table 93: Biomarker Panel - Lupus Nephritis - Product Description 66
  • Table 94: Co-Diagnostics HBDC, Inc. Pipeline Products & Ongoing Clinical Trials Overview 67
  • Table 95: Diagnostic Test - Auto-immune Disorder - Product Status 67
  • Table 96: Diagnostic Test - Auto-immune Disorder - Product Description 67
  • Table 97: Cofactor Genomics Inc Pipeline Products & Ongoing Clinical Trials Overview 68
  • Table 98: RNA Based Diagnostic Test - Multiple Sclerosis - Product Status 68
  • Table 99: RNA Based Diagnostic Test - Multiple Sclerosis - Product Description 68
  • Table 100: RNA Based Diagnostic Test - Parkinson's Disease - Product Status 69
  • Table 101: RNA Based Diagnostic Test - Parkinson's Disease - Product Description 69
  • Table 102: Crescendo Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview 70
  • Table 103: Multi-Biomarker Test - Ankylosing Spondylitis - Product Status 70
  • Table 104: Multi-Biomarker Test - Ankylosing Spondylitis - Product Description 70
  • Table 105: Multi-Biomarker Test - Autoimmune Diseases - Product Status 71
  • Table 106: Multi-Biomarker Test - Autoimmune Diseases - Product Description 71
  • Table 107: Multi-Biomarker Test - Inflammatory Diseases - Product Status 71
  • Table 108: Multi-Biomarker Test - Inflammatory Diseases - Product Description 72
  • Table 109: Multi-Biomarker Test - Psoriatic Arthritis - Product Status 72
  • Table 110: Multi-Biomarker Test - Psoriatic Arthritis - Product Description 72
  • Table 111: Multi-Biomarker Test - Systemic Lupus Erythematosus - Product Status 73
  • Table 112: Multi-Biomarker Test - Systemic Lupus Erythematosus - Product Description 73
  • Table 113: Digna Biotech SL Pipeline Products & Ongoing Clinical Trials Overview 74
  • Table 114: Anti-CD-137 Antibodies Assay - Product Status 74
  • Table 115: Anti-CD-137 Antibodies Assay - Product Description 74
  • Table 116: Prognostic Test - Multiple Sclerosis - Product Status 75
  • Table 117: Prognostic Test - Multiple Sclerosis - Product Description 75
  • Table 118: Durin Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 76
  • Table 119: Diagnostic Test - Parkinson's Disease - Product Status 76
  • Table 120: Diagnostic Test - Parkinson's Disease - Product Description 76
  • Table 121: EMD Millipore Corp Pipeline Products & Ongoing Clinical Trials Overview 77
  • Table 122: Erenna IL-12 Immunoassay Kit - Product Status 77
  • Table 123: Erenna IL-12 Immunoassay Kit - Product Description 77
  • Table 124: Enterome Bioscience SA Pipeline Products & Ongoing Clinical Trials Overview 78
  • Table 125: Diagnostic Test - Multiple Sclerosis - Product Status 78
  • Table 126: Diagnostic Test - Multiple Sclerosis - Product Description 78
  • Table 127: Diagnostic Test - Type 2 Diabetes - Product Status 79
  • Table 128: Diagnostic Test - Type 2 Diabetes - Product Description 79
  • Table 129: Ezose Sciences Inc. Pipeline Products & Ongoing Clinical Trials Overview 80
  • Table 130: Biomarker Diagnostic Assay - Multiple Sclerosis - Product Status 80
  • Table 131: Biomarker Diagnostic Assay - Multiple Sclerosis - Product Description 80
  • Table 132: Flamentera AG Pipeline Products & Ongoing Clinical Trials Overview 81
  • Table 133: Diagnostic Test - Celiac Disease - Product Status 81
  • Table 134: Diagnostic Test - Celiac Disease - Product Description 81
  • Table 135: French National Institute of Health and Medical Research Pipeline Products & Ongoing Clinical Trials Overview 82
  • Table 136: Blood Based CRMP Biomarker Assay - Multiple Sclerosis - Product Status 82
  • Table 137: Blood Based CRMP Biomarker Assay - Multiple Sclerosis - Product Description 82
  • Table 138: Genalyte, Inc. Pipeline Products & Ongoing Clinical Trials Overview 83
  • Table 139: Maverick ANA 11 Assay Kit - Product Status 83
  • Table 140: Maverick ANA 11 Assay Kit - Product Description 83
  • Table 141: GeNeuro SA Pipeline Products & Ongoing Clinical Trials Overview 84
  • Table 142: GNbAC1 Test - Multiple Sclerosis - Product Status 84
  • Table 143: GNbAC1 Test - Multiple Sclerosis - Product Description 84
  • Table 144: Glycominds Ltd. Pipeline Products & Ongoing Clinical Trials Overview 85
  • Table 145: gMS DMT - Product Status 85
  • Table 146: gMS DMT - Product Description 85
  • Table 147: Grifols SA Pipeline Products & Ongoing Clinical Trials Overview 86
  • Table 148: Diagnostic Test - Autoimmunity - Product Status 86
  • Table 149: Diagnostic Test - Autoimmunity - Product Description 86
  • Table 150: Hannover Medical School Pipeline Products & Ongoing Clinical Trials Overview 87
  • Table 151: Diagnostic Test - Multiple Sclerosis - Product Status 87
  • Table 152: Diagnostic Test - Multiple Sclerosis - Product Description 87
  • Table 153: Helmholtz Centre for Infection Research Pipeline Products & Ongoing Clinical Trials Overview 88
  • Table 154: ELISA Based Assay - Rheumatic Fever - Product Status 88
  • Table 155: ELISA Based Assay - Rheumatic Fever - Product Description 88
  • Table 156: HOB Biotech Group Suzhou Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 89
  • Table 157: HOB Biotech Diagnostic Assay - Auto-immunity - Product Status 89
  • Table 158: HOB Biotech Diagnostic Assay - Auto-immunity - Product Description 89
  • Table 159: Hospital for Special Surgery Pipeline Products & Ongoing Clinical Trials Overview 90
  • Table 160: Lupus Biomarkers - Product Status 90
  • Table 161: Lupus Biomarkers - Product Description 90
  • Table 162: Hummingbird Diagnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview 91
  • Table 163: Diagnostic Test - IBD - Product Status 91
  • Table 164: Diagnostic Test - IBD - Product Description 91
  • Table 165: Diagnostic Test - Multiple Sclerosis - Product Status 92

List of Figures

1.2 List of Figures

  • Figure 1: Auto-Immune Diseases Diagnostic Tests - Pipeline Products by Stage of Development 21
  • Figure 2: Auto-Immune Diseases Diagnostic Tests - Pipeline Products by Territory 22
  • Figure 3: Auto-Immune Diseases Diagnostic Tests - Pipeline Products by Regulatory Path 23
  • Figure 4: Auto-Immune Diseases Diagnostic Tests - Pipeline Products by Estimated Approval Date 24
  • Figure 5: Auto-Immune Diseases Diagnostic Tests - Ongoing Clinical Trials 25
Back to Top